• Entity registrant name: ISRAEL CHEMICALS LTD. (CIK: 0000941221)
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/941221/000095010318003092/0000950103-18-003092-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/941221/000095010318003092/icl-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • XBRL Cloud Rendering (requires license): Click to open XBRL Cloud Component Rendering
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0000941221
  • Open this page in separate window: Click

    • * * *

    Component: (Network and Table)
    Network
    00500 - Statement - Consolidated Statements of Cash Flows
    (http://www.icl-group.com/role/ConsolidatedStatementsOfCashFlows)
    Table (Implied)
    Slicers (applies to each fact value in each table cell)
    Reporting Entity [Axis] 0000941221 (http://www.sec.gov/CIK)
    Statements of Cash Flows [Abstract] Period [Axis]
    2017-01-01 - 2017-12-31
    2016-01-01 - 2016-12-31
    2015-01-01 - 2015-12-31
    Statements of Cash Flows [Abstract]
     
     
     
    Cash flows from operating activities
     
     
     
    Net income (loss)
    347,000,000  
    (172,000,000) 
    506,000,000  
    Adjustments for
     
     
     
    Depreciation and amortization
    390,000,000  
    401,000,000  
    355,000,000  
    Impairment
    28,000,000  
    5,000,000  
    75,000,000  
    Revaluation of balances from financial institutions and interest expenses, net
    137,000,000  
    76,000,000  
    44,000,000  
    Share in earnings of equity-accounted investees, net
    0  
    (18,000,000) 
    (11,000,000) 
    Other capital losses (gains), net
    (54,000,000) 
    433,000,000  
    (210,000,000) 
    Share-based compensation
    16,000,000  
    15,000,000  
    15,000,000  
    Deferred tax expenses (income)
    (46,000,000) 
    (2,000,000) 
    5,000,000  
    Adjustments for reconcile profit loss
    471,000,000  
     
    910,000,000  
     
    273,000,000  
     
    Change in inventories
    57,000,000  
    70,000,000  
    25,000,000  
    Change in trade and other receivables
    21,000,000  
    150,000,000  
    (86,000,000) 
    Change in trade and other payables
    (45,000,000) 
    (90,000,000) 
    (55,000,000) 
    Change in provisions and employee benefits
    (4,000,000) 
    98,000,000  
    (90,000,000) 
    Net change in operating assets and liabilities
    29,000,000  
     
    228,000,000  
     
    (206,000,000) 
     
    Net cash provided by operating activities
    847,000,000  
     
    966,000,000  
     
    573,000,000  
     
    Cash flows from investing activities
     
     
     
    Investments in shares and proceeds from deposits, net
    (65,000,000) 
    (198,000,000) 
    34,000,000  
    Business combinations, net of cash acquired
    0  
    0  
    (351,000,000) 
    Purchases of property, plant and equipment and intangible assets
    (457,000,000) 
    (632,000,000) 
    (619,000,000) 
    Proceeds from divestiture of subsidiaries
    6,000,000  
    17,000,000  
    364,000,000  
    Proceeds from sale of equity accounted investee
    168,000,000  
    0  
    0  
    Dividends from equity-accounted investees
    3,000,000  
    12,000,000  
    19,000,000  
    Proceeds from sale of property, plant and equipment
    12,000,000  
    0  
    0  
    Other
    0  
    1,000,000  
    6,000,000  
    Net cash used in investing activities
    (333,000,000) 
     
    (800,000,000) 
     
    (547,000,000) 
     
    Cash flows from financing activities
     
     
     
    Dividend paid to the company's shareholders
    (237,000,000) 
    (162,000,000) 
    (347,000,000) 
    Receipt (Repayment) of long-term debt, net
    (421,000,000) 
    (87,000,000) 
    355,000,000  
    Short-term credit from banks and others, net
    147,000,000  
    14,000,000  
    8,000,000  
    Other
    0  
    (4,000,000) 
    (1,000,000) 
    Net cash provided by (used in) financing activities
    (511,000,000) 
     
    (239,000,000) 
     
    15,000,000  
     
    Cash and cash equivalents as at the beginning of the year
    87,000,000  
    161,000,000  
    138,000,000  
    Net change in cash and cash equivalents
    3,000,000  
     
    (73,000,000) 
     
    41,000,000  
     
    Net effect of currency translation on cash and cash equivalents
    (2,000,000) 
    (1,000,000) 
    (18,000,000) 
    Cash and cash equivalents included as part of assets held for sale
    (5,000,000) 
    0  
    0  
    Cash and cash equivalents as at the end of the year
    83,000,000  
     
    87,000,000  
     
    161,000,000  
     
    Statements of Cash Flows - Additional Information
     
     
     
    Income taxes paid, net of tax refunds
    127,000,000  
    84,000,000  
    20,000,000  
    Interest paid
    111,000,000  
    112,000,000  
    87,000,000